Alexandria Real Estate Equities

What Alexandria Real Estate Equities does

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a publicly traded S&P 500 real estate investment trust founded in 1994 by Joel S. Marcus that pioneered the life science REIT category. The company develops, owns, and operates 375 properties totaling approximately 42.9 million square feet (35.8M RSF of operating assets as of March 31, 2026) across seven major U.S. innovation clusters: Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.

Alexandria's core offering is the Alexandria Megacampus platform, a purpose-built collaborative campus ecosystem designed for the operational and infrastructure needs of life science and technology companies. The platform provides mission-critical laboratory and office space with specialized infrastructure (HVAC, gas lines, waste systems), curated amenities, healthy building certifications (LEED Gold/Platinum, Fitwel, WELL), and operational excellence tailored to research and development workflows. Tenants span biotech, large-cap pharmaceutical, agritech, and academic medical center segments under multi-year operating leases (typically 5-20+ years) with periodic escalations.

The company generates revenue primarily through rental income from laboratory and office leases, supplemented by development fees and construction revenue, and unrealized returns from the Alexandria Ventures strategic venture capital platform (which generated $506M in unrealized gains and $1.2B in adjusted cost basis as of December 31, 2022). Distribution is exclusively direct-to-tenant through enterprise field sales teams in each innovation cluster, with no intermediaries or broker channels. Complementary verticals include Alexandria Summit (thought leadership convening founded 2011) and Alexandria Lifeline (employee healthcare benefit program). As of March 31, 2026, the company had a $20.44 billion market capitalization but was navigating significant sector headwinds: operating occupancy had declined to 87.7% from 94.6% at year-end 2024, full-year 2025 produced an $8.44 net loss per share driven by $2.2 billion in real estate impairments, and the company executed a 45% dividend cut alongside $3 billion in planned 2026 asset dispositions to reduce leverage.

Name

Alexandria Real Estate Equities

Legal name

Alexandria Real Estate Equities, Inc.

Website

https://are.com

Company type

Public

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Alexandria Real Estate Equities (NYSE: ARE) is an S&P 500 life science REIT that owns, develops, and operates 375 purpose-built Megacampus properties totaling approximately 42.9 million square feet across seven U.S. innovation clusters, leasing mission-critical laboratory and office space to biotech, pharmaceutical, agritech, and academic medical center tenants through direct enterprise field sales under long-term operating leases.

Ownership category

akta.pro rank

Product category

Life Science Real Estate

NAICS

Real Estate Property Managers (53131), Rental and Leasing Services (532), Portfolio Management and Investment Advice (523940)

SIC

Real Estate Investment Trusts (6798), Real Estate (6500)

akta.pro primary industry

Life Sciences/Laboratory Property Management (BPAJAGAL)

akta.pro secondary industries

Real Estate Development & Feasibility Advisory (Highest-and-Best-Use, Entitlements Support) (BPAJANAC), Life Sciences/Lab Tenant Representation (BPAJALAG)

Keywords

• Life science real estate
• Laboratory office leasing
• Biotech campus development
• Commercial property REIT
• Venture capital investing

Headquarters

HQ city

Pasadena

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Commercial Real Estate Rental Revenue: Alexandria generates the substantial majority of its revenue through rental income from leasing laboratory, office, and research and development space to life science and technology tenants. Rental revenue is earned under long-term operating leases with periodic escalations, typically 5-20 year terms with renewal options. Tenants include biotech, pharma, agtech, and medical research organizations across key U.S. innovation clusters.
2. Venture Investment Returns: Alexandria Ventures, the company's strategic venture capital platform, has invested in disruptive life science companies since 1996. The platform generated $506 million in on-balance-sheet unrealized gains and $1.2 billion in adjusted cost basis as of December 31, 2022. Returns from successful exits include Intra-Cellular Therapies (acquired by Johnson & Johnson for $14.6 billion) and Petra Pharmaceuticals (acquired by Eli Lilly in 2020).
3. Development and Construction Services: Alexandria develops purpose-built life science facilities for tenants, generating development fees and construction revenue as part of its capital recycling strategy. The company maintains a $6.9 billion development pipeline representing approximately 17% of gross assets, with projects designed to LEED Gold or Platinum certification and targeting Fitwel or WELL certification.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Alexandria Real Estate Equities is a publicly traded life science REIT that owns, develops, and operates mission-critical laboratory, office, and R&D facilities for life science and technology tenants across seven major U.S. innovation clusters. The company leases purpose-built collaborative campus environments (Alexandria Megacampus™) to biotech, pharmaceutical, agritech, and medical research organizations under multi-year operating leases, and operates a complementary strategic venture capital arm (Alexandria Ventures®) that invests in disruptive life science companies.

Product overview

Alexandria Real Estate Equities is a life science Real Estate Investment Trust (REIT) operating as a single unified platform centered on the Alexandria Megacampus™ real estate offering. The company provides laboratory and office space to life science and technology tenants across seven major innovation clusters in the United States. In addition to its core real estate business, the company operates complementary business verticals including Alexandria Ventures® for venture investments in life science companies, Alexandria Summit® for thought leadership convenings, and Alexandria Lifeline™ for employee healthcare benefits. The company does not offer modular software products or technology platforms; its offering is entirely focused on physical real estate assets and associated services.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Alexandria's combined leasing volume in Greater Boston, San Francisco Bay Area, and San Diego totaled approximately 105% of aggregate square footage leased by the next five largest life science real estate owners combined (2023–September 2025)
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Foundation for the National Institutes of Health (FNIH)coreStrategic or Co-development Partner · 1 January 2025Alexandria entered into a public-private partnership with the Foundation for the National Institutes of Health focused on depression research through the MAP-D program, announced in connection with Mental Health Awareness Month 2026. The partnership advances Alexandria's mission to support human health and builds on the company's role in the life science ecosystem, with 39% of the 44 FDA novel drug approvals in 2025 coming from Alexandria tenants.
• Navy SEAL FoundationcoreOthers · 1 January 2010Alexandria Real Estate Equities has been an active supporter of the Navy SEAL Foundation since 2010, providing direct program funding including the Warrior Fitness Program facility in San Diego that opened in November 2023. The program served 344 warriors in 2025, a 67% increase over two years, with active-duty participants improving cognitive scores by an average of 11.8 points in 2024. Joel Marcus, founder and executive chairman, received the 2020 Patriot Award for contributions to the Foundation.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Healthpeak Properties: Publicly traded healthcare and life science REIT with a meaningful lab and medical office portfolio. Compares to Alexandria in serving life science tenants in major innovation hubs and shares a similar capital-recycling and development-oriented strategy.
• Boston Properties (BXP): Large-cap publicly traded office and life science REIT operating in Cambridge/Boston, San Francisco, and other innovation clusters. Most directly comparable peer given its scale, public-market profile, and significant life science exposure that overlaps with Alexandria's flagship clusters.
• Cousins Properties: Sun Belt-focused office REIT with an emerging life science strategy, including developments in Austin and Atlanta. Comparable to Alexandria as a publicly traded REIT expanding into life science lab space, though at a smaller and more regionally concentrated scale.
• Kilroy Realty Corporation: West Coast-focused office and life science REIT with concentrated holdings in the San Francisco Bay Area, Los Angeles, and Seattle. Directly comparable to Alexandria's life science portfolio along the West Coast and similar high-end tenant base.
• BioMed Realty (Blackstone): Major private life science REIT owned by Blackstone, operating lab and office space in key innovation clusters including San Diego, San Francisco, Boston, and Cambridge. Closest direct private-market peer to Alexandria's Megacampus model and tenant base.

Broad incumbents

• Highwoods Properties: Sun Belt-focused office REIT with growing life science exposure in select markets such as Atlanta and Raleigh. Comparable as a publicly traded office REIT beginning to compete in life science, but primarily a broader incumbent in the office sector.

Emerging players

• IQHQ (Blackstone): Pure-play life science REIT (now under Blackstone ownership) developing premier lab campuses in San Diego, San Francisco, and Boston. Comparable to Alexandria's Megacampus concept, though with a younger portfolio and less entrenched tenant relationships.
• Brandywine Realty Trust: Office REIT with a defined life science growth strategy along the East Coast, including Philadelphia and Austin. Compares to Alexandria as a publicly traded peer transitioning into life science, but with much smaller lab exposure and a different geographic mix.
• Longfellow Real Estate Partners: Private life science developer and operator with major campuses in Boston/Cambridge and the San Francisco Bay Area. Comparable niche focus and tenant profile to Alexandria, but at significantly smaller scale.
• Breakthrough Properties: Joint venture between Tishman Speyer and Bellco Capital focused exclusively on developing and operating life science real estate in gateway markets. Comparable to Alexandria in product and cluster focus, but as an emerging private developer with a much smaller footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=U8w_7HgkkZ8
• LinkedInlinkedin.com/company/alexandria-real-estate-equities-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds7 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments57 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alexandria Real Estate Equities